More than 130 medical devices were approved by the FDA since January 2018

The market landscape is highly fragmented, featuring the presence of both established players and new entrants; majority of such firms are located in the developed geographies

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Safe Website to Buy rs3 gold with Up to 8% off for Runescape Soul Wars Improvements

Despite mammalian cell cultures being the preferred manufacturing approach for biologics

A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules

Presently, in silico tools / approaches are available for the identification

Majority of the companies offer structure-based drug design focused on early stage drug discovery of a range of large molecules, including antibodies, proteins and peptides

A detailed assessment of the current market landscape of companies offering in silico drug discovery services for large molecules.

A detailed brand positioning analysis of key industry players, highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects

Over 150 software solutions are currently available for use in drug discovery

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

Around 100 handheld ultrasound imaging devices, incorporating different transducer arrays and advanced software, are being actively used by physicians to scan different body parts.

A detailed assessment of the current market landscape of companies engaged in the development / manufacturing of handheld ultrasound imaging devices

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various aspects of their respective microbial biologic development programs.

The market features the presence of several well-established players across the globe

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment

A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018

Currently, there are a number of contract research organizations (CROs) that claim to have the necessary capabilities to offer in vitro ADME services.

Several players involved in this domain are steadily expanding their capabilities in order to enhance their respective in the in vitro

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME)

Nearly 60% of these companies are small and mid-sized firms. Further, close to 35% of the CROs engaged in this domain, claim to provide services to both pharmaceutical companies and academic institutes.

A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework

Despite having captured the interest of several venture capital firms and big pharma players

Prevalent trends indicate that microbiome drugs and diagnostics market is poised to grow significantly

An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community

An informative analysis of contemporary Google Trends in the time period between 2015 and 2020 (till July) and insights from the recent news articles related digital therapeutic solutions, indicating the increasing popularity of this domain.

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

The projected market opportunity is anticipated to be well-distributed across different therapeutic areas, distribution channels and key geographical regions

Elaborate profiles of key industry players that offer a several digital therapeutic solutions (shortlisted on the basis of the product portfolio).

The market in Asia-Pacific regions is anticipated to grow at a relatively faster pace (23.2%). In 2030,

A detailed demand and supply assessment of geographies, based on a number of parameters.

Biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers.

The market landscape features the presence of well- established players in the domain

Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.

A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.

Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device

Several big pharma companies are actively engaged in strengthening their pipeline of injectable drugs across various therapeutic areas

A detailed overview of the current market landscape of companies engaged in manufacturing prefilled syringes.

An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics

The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics

“Global Psychedelic Therapeutics Market, 2020-2030”

Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.

As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.

The current landscape includes a mix of both established players and new entrants; close to 40% of the companies offering proteome profiling services were established over the last two decades